The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Breast Cancer Cells in Three-dimensional Culture Display an Enhanced Radioresponse after Coordinate Targeting of Integrin α5β1 and Fibronectin
Open accessPublished version of a preprint
Abstract
Tactics to selectively enhance cancer radioresponse are of great interest. Cancer cells actively elaborate and remodel their extracellular matrix (ECM) to aid in survival and progression. Previous work has shown that β1-integrin inhibitory antibodies can enhance the growth-inhibitory and apoptotic responses of human breast cancer cell lines to ionizing radiation, either when cells are cultured in three-dimensional laminin-rich ECM (3D lrECM) or grown as xenografts in mice. Here, we show that a specific α heterodimer of β1-integrin preferentially mediates a prosurvival signal in human breast cancer cells that can be specifically targeted for therapy. 3D lrECM culture conditions were used to compare α-integrin heterodimer expression in malignant and nonmalignant cell lines. Under these conditions, we found that expression of α5β1-integrin was upregulated in malignant cells compared with nonmalignant breast cells. Similarly, we found that normal and oncofetal splice variants of fibronectin, the primary ECM ligand of α5β1-integrin, were also strikingly upregulated in malignant cell lines compared with nonmalignant acini. Cell treatment with a peptide that disrupts the interactions of α5β1-integrin with fibronectin promoted apoptosis in malignant cells and further heightened the apoptotic effects of radiation. In support of these results, an analysis of gene expression array data from breast cancer patients revealed an association of high levels of α5-integrin expression with decreased survival. Our findings offer preclinical validation of fibronectin and α5β1-integrin as targets for breast cancer therapy. Cancer Res; 70(13); 5238–48. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Nam et al. demonstrated that human breast cancer cells in 3D culture overexpressed a cell adhesion molecule a 5 b 1-integrin compared to nonmalignant cells, which can be specifically targeted for therapy. 66”
From Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors (2014) · cites this paper as [66]
The cited source says what the claim attributes to it.
In the citing paper
“They then found a small peptide inhibitor that can prevent a 5 b 1integrin from binding to fibronectin, thus increases the cell killing effect of radiation.”
From Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors (2014) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,697
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,534
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
New Perspectives in Cell Adhesion: RGD and Integrins
Ruoslahti, E. I., & Pierschbacher, M. D. (1987) · Science · doi:10.1126/science.2821619 · Cited by 4,875
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppé, J., Tong, F. K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,224
Taking Cell-Matrix Adhesions to the Third Dimension
Cukierman, E., Pankov, R., Stevens, D. R., & Yamada, K. M. (2001) · Science · doi:10.1126/science.1064829 · Cited by 3,027
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1 · Cited by 1,546
Three-dimensional culture models of normal and malignant breast epithelial cells
Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336
Self-citation
Cited by
Sorted by citations
Edmondson, R., Broglie, J. J., Adcock, A. F., & Yang, L. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2014.573 · Cited by 2,515
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Henke, E., Nandigama, R., & Ergün, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00160 · Cited by 1,142
RNA splicing dysregulation and the hallmarks of cancer
Bradley, R. K., & Anczuków, O. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00541-7 · Cited by 579
Peltanová, B., Raudenská, M., & Masařík, M. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0983-5 · Cited by 496
Urbanski, L. M., Leclair, N. K., & Anczuków, O. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1476 · Cited by 393
Focal adhesion signaling and therapy resistance in cancer
Eke, I., & Cordes, N. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.009 · Cited by 339
Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
Schaffner, F., Ray, A., & Dontenwill, M. (2013) · Cancers · doi:10.3390/cancers5010027 · Cited by 234
Spada, S., Tocci, A., Modugno, F. D., & Nisticò, P. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01908-8 · Cited by 191
3D scaffolds in breast cancer research
Rijal, G., & Li, W. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.016 · Cited by 169
Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
Wang, J. P., & Hielscher, A. C. (2017) · Journal of Cancer · doi:10.7150/jca.16901 · Cited by 174
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
Huang, C., Park, C. C., Hilsenbeck, S. G., Ward, R., Rimawi, M. F., Wang, Y.-C., Shou, J., Bissell, M. J., Osborne, C. K., & Schiff, R. (2011) · Breast Cancer Research · doi:10.1186/bcr2936 · Cited by 165
Self-citationYeh, Y.-C., Ling, J.-Y., Chen, W.-C., Lin, H., & Tang, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14932-6 · Cited by 162
Serres, É., Debarbieux, F. C., Stanchi, F., Maggiorella, L., Grall, D., Turchi, L., Burel‐Vandenbos, F., Figarella‐Branger, D., Virolle, T., Rougon, G., et al. (2013) · Oncogene · doi:10.1038/onc.2013.305 · Cited by 169
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
Menon, H., Ramapriyan, R., Cushman, T. R., Verma, V., Kim, H. H., Schoenhals, J. E., Atalar, S. C., Selek, U., Chun, S. G., Chang, J. Y., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00193 · Cited by 160
Shaping Up the Tumor Microenvironment With Cellular Fibronectin
Efthymiou, G., Saint, A., Ruff, M., Rekad, Z., Ciais, D., & Obberghen‐Schilling, E. V. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00641 · Cited by 160
Kollmannsberger, P., Bidan, C. M., Dunlop, J., Fratzl, P., & Viola Vogel, B. (2018) · Science Advances · doi:10.1126/sciadv.aao4881 · Cited by 158
The Roles of Integrin α5β1 in Human Cancer
Hou, J., Du, Y. Z., Liu, Y., Huang, P., & Cui, H. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s273803 · Cited by 148
Biomaterials‐Based Approaches to Tumor Spheroid and Organoid Modeling
Thakuri, P. S., Liu, C., Luker, G. D., & Tavana, H. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700980 · Cited by 142
Hurst, D. R., & Welch, D. R. (2011) · International review of cytology · doi:10.1016/b978-0-12-385859-7.00003-3 · Cited by 140
Unnikrishnan, A., Papaemmanuil, E., Beck, D., Deshpande, N., Verma, A., Kumari, A., Woll, P. S., Richards, L. A., Knezevic, K., Chandrakanthan, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.067 · Cited by 137
Kuninty, P. R., Bansal, R., de Geus, S. W. L., Mardhian, D. F., Schnittert, J., van Baarlen, J., Storm, G., Bijlsma, M. F., van Laarhoven, H. W. M., Metselaar, J. M., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax2770 · Cited by 137
Janoušková, H., Maglott, A., Leger, D. Y., Bossert, C., Noulet, F., Guérin, É., Guénot, D., Pinel, S., Chastagner, P. B., Plénat, F., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4199 · Cited by 132
Wu, P., Onodera, Y., Ichikawa, Y., Rankin, E. B., Giaccia, A. J., Watanabe, Y., Qian, W. P., Hashimoto, T., Shirato, H., & Nam, J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s137833 · Cited by 134
Self-citationHuck, L., Pontier, S. M., Zuo, D., & Muller, W. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003034107 · Cited by 131
Targeting fibronectin for cancer imaging and therapy
Han, Z., & Lu, Z. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02008a · Cited by 108
Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
Wu, P., Opadele, A. E., Onodera, Y., & Nam, J. (2019) · Cancers · doi:10.3390/cancers11111783 · Cited by 110
Self-citationArpaia, E., Blaser, H., Quintela-Fandiño, M., Duncan, G. S., Leong, H. S., Ablack, A. L., Nambiar, S. C., Lind, E. F., Silvester, J., Fleming, C., et al. (2011) · Oncogene · doi:10.1038/onc.2011.288 · Cited by 108
The Extracellular, Cellular, and Nuclear Stiffness, a Trinity in the Cancer Resistome—A Review
Deville, S. S., & Cordes, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01376 · Cited by 105
Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles
Zhang, B., Shen, S., Liao, Z., Shi, W., Wang, Y., Zhao, J., Hu, Y., Yang, J., Chen, J., Mei, H., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.046 · Cited by 101
Ansems, M., & Span, P. N. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.04.001 · Cited by 103
A top-down view of the tumor microenvironment: structure, cells and signaling
Bhome, R., Bullock, M. D., AlSaihati, H., Goh, R. W., Primrose, J. M., Sayan, E., & Mirnezami, A. H. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00033 · Cited by 101
Qin, L., Chen, X., Wu, Y., Feng, Z., He, T., Wang, L., Liao, L., & Xu, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3453 · Cited by 97
Berger, A. J., Renner, C. M., Hale, I., Yang, X., Ponik, S. M., Weisman, P. S., Masters, K. S. B., & Kreeger, P. K. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.07.006 · Cited by 97
The Role of Extracellular Matrix Proteins in Breast Cancer
Lepucki, A., Orlińska, K., Mielczarek‐Palacz, A., Kabut, J., Olczyk, P., & Komosińska‐Vassev, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051250 · Cited by 104
Kopp, S., Slumstrup, L., Corydon, T. J., Sahana, J., Aleshcheva, G., Islam, T., Magnusson, N. E., Wehland, M., Bauer, J. W., Infanger, M., et al. (2016) · Scientific Reports · doi:10.1038/srep26887 · Cited by 94
Cancer Cell Invasion Is Enhanced by Applied Mechanical Stimulation
Menon, S., & Beningo, K. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017277 · Cited by 96
Kirsch, D. G., Diehn, M., Kesarwala, A. H., Maity, A. M., Morgan, M. A., Schwarz, J. K., Bristow, R. G., Demaria, S., Eke, I., Griffin, R. J., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx231 · Cited by 96
Self-citationAhmed, K. M., Zhang, H., & Park, C. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3537 · Cited by 95
Self-citationCancer cell migration on elongate protrusions of fibroblasts in collagen matrix
Miyazaki, K., Oyanagi, J., Hoshino, D., Togo, S., Kumagai, H., & Miyagi, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-36646-z · Cited by 100
Onodera, Y., Nam, J., Horikawa, M., Shirato, H., & Sabe, H. (2018) · Nature Communications · doi:10.1038/s41467-018-05087-7 · Cited by 87
Self-citationRole of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer
Silva, E. C. D., Dontenwill, M., Choulier, L., & Lehmann, M. (2019) · Cancers · doi:10.3390/cancers11050692 · Cited by 81
Current Advances in 3D Dynamic Cell Culture Systems
Huang, X., Huang, Z., Gao, W., Gao, W., He, R., Li, Y., Crawford, R., Zhou, Y., Xiao, L., & Xiao, Y. (2022) · Gels · doi:10.3390/gels8120829 · Cited by 91
Renner, G., Janoušková, H., Noulet, F., Koenig, V., Guérin, É., Bär, S., Nüesch, J. P. F., Rechenmacher, F., Neubauer, S., Kessler, H., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2015.131 · Cited by 80
Cao, Y., Liu, X., Lü, W., Chen, Y., Wu, X., Li, M., Wang, X.-A., Zhang, F., Jiang, L., Zhang, Y., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.041 · Cited by 75
Miroshnikova, Y. A., Rozenberg, G. I., Cassereau, L., Pickup, M. W., Mouw, J. K., Ou, G., Templeman, K. L., Hannachi, E.-I., Gooch, K. J., Sieminski, A. L., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-02-0126 · Cited by 74
Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness
Ward, C., Meehan, J., Gray, M., Kunkler, I. H., Langdon, S. P., & Argyle, D. J. (2018) · Metabolites · doi:10.3390/metabo8010013 · Cited by 76
Yeh, Y.-C., Lin, H., & Tang, M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2012 · Cited by 72
Integrin signaling in control of tumor growth and progression
Xiong, J., Balcioglu, H. E., & Danen, E. H. J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.005 · Cited by 70
β1 and β4 integrins: from breast development to clinical practice
Nisticò, P., Modugno, F. D., Spada, S., & Bissell, M. J. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0459-x · Cited by 69
Self-citationThe cancer cell adhesion resistome: mechanisms, targeting and translational approaches
Dickreuter, E., & Cordes, N. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0326 · Cited by 67
Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells
Berg, T. J., & Pietras, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.011 · Cited by 64
The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation
Wu, Q., Madany, P., Akech, J., Dobson, J. R., Douthwright, S., Browne, G., Colby, J. L., Winter, G. E., Bradner, J. E., Pratap, J., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24991 · Cited by 63
How integrins control breast biology
Glukhova, M. A., & Streuli, C. H. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.06.010 · Cited by 59
Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment
Nisar, S., Yousuf, P., Masoodi, T., Wani, N. A., Hashem, S., Singh, M. K., Sageena, G., Mishra, D., Kumar, R., Haris, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094584 · Cited by 63
Eke, I., Storch, K., Krause, M., & Cordes, N. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0344 · Cited by 63
Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment
Longmate, W. M., & DiPersio, C. M. (2017) · F1000Research · doi:10.12688/f1000research.11877.1 · Cited by 57
Zhou, X., Zhai, Y., Liu, C., Yang, G., Guo, J., Li, G., Sun, C., Qi, X., Li, X., & Guan, F. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-019-0500-x · Cited by 56
Emerging trends in the methodology of environmental toxicology: 3D cell culture and its applications
Wang, H., Xu, T., & Yin, D. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159501 · Cited by 57
The disintegrin tzabcanin inhibits adhesion and migration in melanoma and lung cancer cells
Saviola, A. J., Burns, P. D., Mukherjee, A. K., & Mackessy, S. P. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.04.008 · Cited by 55
Goel, H. L., Sayeed, A., Breen, M., Zarif, M. J., Garlick, D. S., Leav, I., Davis, R. J., FitzGerald, T. J., Morrione, A., Hsieh, C., et al. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24323 · Cited by 52
Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures
Eke, I., & Cordes, N. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.006 · Cited by 52
Grassian, A. R., Schafer, Z. T., & Brugge, J. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169821 · Cited by 51
Radiotherapy and the Tumor Microenvironment: Mutual Influence and Clinical Implications
Thompson, R. F., & Maity, A. M. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_7 · Cited by 51
Wu, P., Onodera, Y., Giaccia, A. J., Le, Q., Shimizu, S., Shirato, H., & Nam, J. (2020) · Communications Biology · doi:10.1038/s42003-020-01339-9 · Cited by 47
Self-citationIntegrin Signaling as a Cancer Drug Target
Danen, E. H. J. (2013) · ISRN Cell Biology · doi:10.1155/2013/135164 · Cited by 49
Cancer Mechanobiology: Microenvironmental Sensing and Metastasis
Lee, G., Han, S., Lee, J., Kim, H., & Kim, D. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01230 · Cited by 47
Robertson, C. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.11.009 · Cited by 45
Mohamed, M. M. (2012) · Cell Communication and Signaling · doi:10.1186/1478-811x-10-3 · Cited by 45
The mesenchymal tumor microenvironment
Cukierman, E., & Bassi, D. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20210 · Cited by 45
Role of α5β1 Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells
Yao, H., Zeng, Z.-Z., Fay, K. S., Veine, D. M., Staszewski, E. D., Morgan, M. A., Wilder-Romans, K., Williams, T. M., Spalding, A. C., Ben‐Josef, E., et al. (2011) · Translational Oncology · doi:10.1593/tlo.11133 · Cited by 45
Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells
Sampayo, R. G., Toscani, A. M., Rubashkin, M. G., Thi, K., Masullo, L. A., Violi, I. L., Lakins, J. N., Cáceres, A., Hines, W. C., Leskow, F. C., et al. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201703037 · Cited by 46
Self-citationEnhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition
Eke, I., Dickreuter, E., & Cordes, N. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.05.009 · Cited by 44
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Martín-Otal, C., Lasarte-Cía, A., Serrano, D., Casares, N., Conde, E., Navarro, F. C., Sánchez-Moreno, I., Gorraiz, M., Sarrión, P., Calvo, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004479 · Cited by 45
Tan, X., Liu, Z., Wang, Y., Wu, Z., Zou, Y., Luo, S., Tang, Y., Chen, D., Yuan, G., & Yao, K. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05261-2 · Cited by 42
Intracellular trafficking of integrins in cancer cells
Onodera, Y., Nam, J., & Sabe, H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.007 · Cited by 42
Self-citationJung, A. C., Ray, A., Ramolu, L., Macabre, C., Simon, F., Noulet, F., Blandin, A.-F., Renner, G., Lehmann, M., Choulier, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6099 · Cited by 41
Brandão-Costa, R. M., Helal‐Neto, E., Vieira, A. M., Barcellos‐de‐Souza, P., Morgado‐Díaz, J. A., & Barja‐Fidalgo, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082995 · Cited by 42
Tanaka, R., Seki, Y., Saito, Y., Kamiya, S., Fujita, M., Okutsu, H., Iyoda, T., Takai, T., Owaki, T., Yajima, H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.546622 · Cited by 40
Mythreye, K., Knelson, E. H., Gatza, C. E., Gatza, M. L., & Blobe, G. C. (2012) · Oncogene · doi:10.1038/onc.2012.157 · Cited by 41
Raof, N. A., Raja, W. K., Castracane, J., & Xie, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.035 · Cited by 39
Acoustic tweezers for studying intracellular calcium signaling in SKBR-3 human breast cancer cells
Hwang, J. Y., Yoon, C. W., Lim, H. G., Park, J. M., Yoon, S., Lee, J., & Shung, K. K. (2015) · Ultrasonics · doi:10.1016/j.ultras.2015.06.017 · Cited by 39
Nam, J., Ahmed, K. M., Costes, S. V., Zhang, H., Onodera, Y., Olshen, A. B., Hatanaka, K. C., Kinoshita, R., Ishikawa, M., Sabe, H., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3454 · Cited by 39
Self-citationHuang, C., Verhulst, S. J., Shen, Y., Bu, Y., Cao, Y. W., He, Y., Wang, Y., Huang, D. A., Cai, C., Rao, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9672 · Cited by 38
CYRI-A limits invasive migration through macropinosome formation and integrin uptake regulation
Le, H. A., Yelland, T., Paul, N. R., Fort, L., Nikolaou, S., Ismail, S., & Machesky, L. M. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202012114 · Cited by 38
Closset, L., Gultekin, O., Salehi, S., Sarhan, D., Lehti, K., & Gonzalez‐Molina, J. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.07.003 · Cited by 36
Goliwas, K. F., Richter, J. R., Pruitt, H. C., Araysi, L. M., Anderson, N. R., Samant, R. S., Lobo-Ruppert, S. M., Berry, J. L., & Frost, A. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-14326-8 · Cited by 36
Chemokines and the extracellular matrix: Set of targets for tumor development and treatment
Silva, P., Borges, B. C., Uehara, I. A., Soldi, L. R., de Araújo, R. A., & Silva, M. J. B. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155548 · Cited by 35
Carbon ion irradiation of the human prostate cancer cell line PC3: A whole genome microarray study
Suetens, A., Moreels, M., Quintens, R., Chiriotti, S., Tabury, K., Michaux, A., Grégoire, V., & Baatout, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2287 · Cited by 34
Therapeutic targeting of tumor–stroma interactions
Hiscox, S., Barrett-Lee, P. J., & Nicholson, R. I. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561201 · Cited by 33
Targeting effect of PEGylated liposomes modified with the Arg-Gly-Asp sequence on gastric cancer
Ding, J., Feng, M., Wang, F., Wang, H., & Guan, W. (2015) · Oncology Reports · doi:10.3892/or.2015.4142 · Cited by 33
Lo, F.-Y., Chen, H.-T., Cheng, H.-C., Hsu, H., & Wang, Y. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.05.105 · Cited by 32
3D Cell Models in Radiobiology: Improving the Predictive Value of In Vitro Research
Antonelli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310620 · Cited by 34
Veine, D. M., Yao, H., Stafford, D. R., Fay, K. S., & Livant, D. L. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9634-1 · Cited by 31
Steglich, A., Vehlow, A., Eke, I., & Cordes, N. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.009 · Cited by 30
Rohira, A. D., & Lonard, D. M. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.005 · Cited by 30
Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21Cip1
Cheng, Z., DiMichele, L. A., Rojas, M., Vaziri, C., Mack, C. P., & Taylor, J. M. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.002 · Cited by 29
Sprague, L., Muccioli, M., Pate, M., Singh, M., Xiong, C., Ostermann, A. O., Niese, B., Li, Y., Li, Y., Courreges, M. C., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.031 · Cited by 29
Global profiling of prolactin-modulated transcripts in breast cancer in vivo
Sato, T., Tran, T. H., Peck, A. R., Liu, C., Ertel, A., Lin, J., Neilson, L. M., & Rui, H. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-59 · Cited by 29
Induction of Integrin Signaling by Steroid Sulfatase in Human Cervical Cancer Cells
Ye, D.-J., Kwon, Y., Shin, S., Baek, H., Shin, D.-W., & Chun, Y.-J. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.155 · Cited by 28
Xie, J., Guo, J., Wu, Z., Xu, X., Wu, J., Chen, B., Ran, L.-Q., Liao, L., Li, E., & Xu, L. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.09.029 · Cited by 27
Metadata
- Authors
- Nam, J.-M., Onodera, Y., Bissell, M. J., & Park, C. C.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Park, Catherine C.
- Venue
- Cancer Research
- Published
- 2010-06-30
- Volume
- 70
- Issue
- 13
- Pages
- 5238-5248
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2933183
- OpenAlex
- W2146322233
- Cited by
- 196
- References
- 51
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 11 · 2021: 9 · 2020: 15 · 2019: 11 · 2018: 21 · 2017: 18 · 2016: 11 · 2015: 15 · 2014: 14 · 2013: 20 · 2012: 14
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- University of North Texas Digital Library (University of North Texas) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (22700868)
- National Cancer Institute (R01CA124891, U54CA126552, U54CA143836, R37CA064786, U01CA143233, R01CA057621, U54CA112970)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- breast cancer, alpha5beta1 integrin, fibronectin, radiation response, 3D cell culture, integrin heterodimers, apoptosis, integrin-targeted therapy, patient survival
- MeSH terms
- Breast Neoplasms, Female, Fibronectins, Humans, Infrared Rays, Middle Aged, Peptides, Tumor Cells, Cultured, Up-Regulation, Gene Expression, Apoptosis, Cell Culture Techniques, Protein Isoforms, Integrin alpha5beta1, Integrin alpha5, Cell Line, Tumor, Oncogene Protein v-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review